“With this initiative, the company’s goal is to promote the ownership role of its employees and to connect them more closely with the effectiveness and long-term development of the company group,” said Zsuzsanna Diószegi, managing director of Euroapi Hungary Kft.
The subscription period of the “Euroapi Action 2022” program lasted from June 10-24. In addition to those operating in the Hungarian market, employees from six other countries who work for a subsidiary that is at least 50% owned by Euroapi and has joined the group-level savings plan had the opportunity to benefit from the initiative.
“It is important that the acquired shares are subject to a lock-up period until May 31, 2027, i.e., they cannot be sold for five years, except in a few exceptional cases,” added Cecilia Makláry, HR manager at Euroapi Hungary.
Euroapi focuses on reinventing active ingredient solutions to meet the needs of its partners and patients worldwide. The Hungarian chemical site employs nearly 900 people, manufactures more than 50 active ingredients, and has strong expertise in high-performance materials.
Euroapi is the world’s leading manufacturer of prostaglandins, and among its other products are active ingredients used to treat blood pressure, antispasmodics, and rheumatoid arthritis.
The group develops and sells APIs to more than 500 customers through its API Solutions business unit and contract development and manufacturing organization. Euroapi, the market leader in small molecule active ingredients, currently has a diversified portfolio of around 200 active ingredients.
The company was set up by French pharma giant Sanofi last year as a standalone company to combine Sanofi’s API commercial and development activities with six of its European production sites: Brindisi (Italy), Frankfurt Chemistry (Germany), Haverhill (UK), St Aubin les Elbeuf (France), Újpest (Hungary) and Vertolaye (France).
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
